Population screening for coronary artery calcification does not increase mental distress and the use of psychoactive medication
- PMID: 22336666
- DOI: 10.1097/RTI.0b013e31824752bd
Population screening for coronary artery calcification does not increase mental distress and the use of psychoactive medication
Abstract
Purpose: Detection of coronary artery calcification (CAC) has been proposed for population screening. It remains unknown whether such a strategy would result in unnecessary concern among participants. Therefore, we set out to assess whether CAC screening affects the psychological well-being of screening participants.
Materials and methods: A random sample of 1825 middle-aged subjects (men and women, 50 or 60 y old) were invited for health screening. The European HeartScore was calculated, and a CAC score was measured using a cardiac computed tomography scanner. Therapeutic interventions as a result of the observations were at the discretion of the individual general practitioner. Before screening and at 6-month follow-up a depression test (Major Depression Inventory) was conducted, and the use of psychoactive medication was recorded.
Results: A total of 1257 (69%) subjects agreed to participate. Because of known cardiovascular disease or diabetes mellitus, 88 persons were excluded. Of the remaining 1169, 47% were men, and one half were 50 years old. At 6-month follow-up, significant reductions were observed in the Major Depression Inventory score from 5.3 to 3.9 (P<0.0001) and in the prescription rates of psychoactive medication from 7.1% (83 of 1169) to 6.2% (72 of 1169) (P=0.003). The results were independent of sex, age, HeartScore, CAC Score, and changes in other medication.
Conclusions: A population screening program including CAC score appears to have no detrimental impact on mental distress and does not increase the use of psychoactive medication.
Similar articles
-
Changes in medical treatment six months after risk stratification with HeartScore and coronary artery calcification scanning of healthy middle-aged subjects.Eur J Prev Cardiol. 2012 Dec;19(6):1496-502. doi: 10.1177/1741826711428063. Epub 2011 Oct 21. Eur J Prev Cardiol. 2012. PMID: 22019909
-
Discrepancy between coronary artery calcium score and HeartScore in middle-aged Danes: the DanRisk study.Eur J Prev Cardiol. 2012 Jun;19(3):558-64. doi: 10.1177/1741826711409172. Epub 2011 Apr 27. Eur J Prev Cardiol. 2012. PMID: 21525124
-
Coronary artery calcification outperforms thoracic aortic calcification for the prediction of myocardial infarction and all-cause mortality: the Heinz Nixdorf Recall Study.Eur J Prev Cardiol. 2014 Sep;21(9):1163-70. doi: 10.1177/2047487313482281. Epub 2013 Mar 6. Eur J Prev Cardiol. 2014. PMID: 23467675
-
Ordinal scoring of coronary artery calcifications on low-dose CT scans of the chest is predictive of death from cardiovascular disease.Radiology. 2010 Nov;257(2):541-8. doi: 10.1148/radiol.10100383. Epub 2010 Sep 9. Radiology. 2010. PMID: 20829542
-
Comprehensive coronary risk determination in primary prevention: an imaging and clinical based definition combining computed tomographic coronary artery calcium score and national cholesterol education program risk score.Int J Cardiol. 2006 Jun 16;110(2):129-36. doi: 10.1016/j.ijcard.2005.09.009. Epub 2005 Nov 21. Int J Cardiol. 2006. PMID: 16303191 Review.
Cited by
-
Do Non-participants at Screening have a Different Threshold for an Acceptable Benefit-Harm Ratio than Participants? Results of a Discrete Choice Experiment.Patient. 2019 Oct;12(5):491-501. doi: 10.1007/s40271-019-00364-z. Patient. 2019. PMID: 31165400
-
Short-term mental distress in research participants after receiving cardiovascular risk information.PLoS One. 2019 May 24;14(5):e0217247. doi: 10.1371/journal.pone.0217247. eCollection 2019. PLoS One. 2019. PMID: 31125371 Free PMC article.
-
2016 European Guidelines on cardiovascular disease prevention in clinical practice : The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts).Int J Behav Med. 2017 Jun;24(3):321-419. doi: 10.1007/s12529-016-9583-6. Int J Behav Med. 2017. PMID: 28290077 No abstract available.
-
2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts)Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR).Eur Heart J. 2016 Aug 1;37(29):2315-2381. doi: 10.1093/eurheartj/ehw106. Epub 2016 May 23. Eur Heart J. 2016. PMID: 27222591 Free PMC article. No abstract available.
-
Secondary prevention at 360°: the important role of diagnostic imaging.Radiol Med. 2015 Jun;120(6):511-25. doi: 10.1007/s11547-014-0484-y. Epub 2015 Jan 9. Radiol Med. 2015. PMID: 25572539
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical